Overview
Migraine variants, excluding intractable cases, encompass a spectrum of migraine presentations that deviate from the typical form but do not meet criteria for refractory or chronic migraine. These variants include conditions like basilar-type migraine, hemiplegic migraine, and retinal migraine, each characterized by distinct neurological symptoms 1.Diagnosis
Key Diagnostic Criteria: Specific neurological symptoms accompanying headache (e.g., visual disturbances, motor weakness) 1.
Recommended Tests: Neurological examination, imaging (MRI/CT) to rule out other pathologies 1.
Grading: Severity often assessed based on frequency and impact on daily activities, though standardized grading systems vary 1.Management
First-Line Treatments: Acute: NSAIDs, triptans (specific doses not detailed in abstracts). Preventive: Beta-blockers, anticonvulsants (specific drugs not specified) 1.
Adjunctive Treatments: Behavioral therapies (cognitive-behavioral therapy), lifestyle modifications (stress management, regular sleep patterns) 1.Special Populations
Pregnancy: Management focuses on safe pharmacological options and non-pharmacological interventions due to limited evidence on specific treatments 1.
Pediatrics: Care tailored to age, often emphasizing non-pharmacological approaches initially, with cautious use of pediatric-safe medications 1.
Elderly: Consideration of comorbidities; preventive treatments may include caution with triptans due to cardiovascular risks 1.
Comorbidities: Tailored management considering coexisting conditions; close monitoring for drug interactions and side effects 1.Key Recommendations
Utilize triptans cautiously in special populations due to varying safety profiles across age groups and comorbidities (Evidence: Expert opinion) 1.
Implement preventive strategies early in pediatric cases to mitigate long-term impact (Evidence: Moderate) 1.
Prioritize non-pharmacological interventions alongside pharmacological treatments for all variants to improve quality of life (Evidence: Moderate) 1.References
1 . [Not Available]. Cadernos de saude publica 2024. link
2 . Watching preprints evolve. Nature reviews. Immunology 2021. link
3 Embry TW, Piccirillo JF. Minimal Clinically Important Difference Reporting in Randomized Clinical Trials. JAMA otolaryngology-- head & neck surgery 2020. link
4 Wollenberg B. Editorial Referateband 2018. Laryngo- rhino- otologie 2018. link
5 Annand F. Empowerment for the ophthalmic nurse. Insight (American Society of Ophthalmic Registered Nurses) 1996. link90046-9)